Biography
Dr. Xu Bin is a distinguished Senior Surgical Oncologist at First Hospital of China Medical University with 26 years of dedicated clinical practice. Over the course of an extensive career, Xu Bin has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Xu Bin specializes in the diagnosis and management of complex medical conditions, with particular expertise in Tumor genomic profiling, Breast cancer, CAR-T cell therapy, Colorectal cancer. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Xu Bin for the following conditions and procedures:
- Tumor genomic profiling
- Breast cancer
- CAR-T cell therapy
- Colorectal cancer
Education & Training
- MD Fudan University Shanghai Medical College · Fellowship MD Anderson Cancer Center
Professional Credentials & Memberships
- European Society for Medical Oncology (ESMO)
- Chinese Society of Clinical Oncology Member
- International Association for the Study of Lung Cancer
International Patient Care
Dr. Xu Bin communicates with patients in English, Chinese, Japanese, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD Fudan University Shanghai Medical College · Fellowship MD Anderson Cancer Center
Certifications
- European Society for Medical Oncology (ESMO)
- Chinese Society of Clinical Oncology Member
- International Association for the Study of Lung Cancer